Meeks, Joshua J.
Al-Ahmadie, Hikmat http://orcid.org/0000-0002-2938-6627
Faltas, Bishoy M. http://orcid.org/0000-0002-6432-1693
Taylor, John A. III http://orcid.org/0000-0002-1780-3788
Flaig, Thomas W.
DeGraff, David J.
Christensen, Emil http://orcid.org/0000-0001-7201-3933
Woolbright, Benjamin L.
McConkey, David J.
Dyrskjøt, Lars http://orcid.org/0000-0001-7061-9851
Article History
Accepted: 9 March 2020
First Online: 31 March 2020
Competing interests
: B.M.F. received grant/research support from Eli Lilly and Company and participated in an Advisory Board for Immunomedics. J.J.M. received research support from Epizyme, Tesaro and Abbvie, is a consultant for Ferring and AstraZeneca, and participated in advisory boards for Cold Genesys and Janssen. H.A. is a consultant for AstraZeneca/MedImmune, Bristol-Myers Squibb and EMD Serono. L.D. received research support from Ferring and Natera, and is a consultant for Ferring.